| CSFZX | PGRKX | CSFZX / PGRKX | |
| Total Expense Ratio | 0.84 | 1.46 | 58% |
| Annual Report Gross Expense Ratio | 0.84 | 1.46 | 58% |
| Fund Existence | 12 years | 10 years | - |
| Gain YTD | 6.471 | 6.322 | 102% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.32B | 1.67B | 139% |
| Annual Yield % from dividends | 3.24 | 1.87 | 173% |
| Returns for 1 year | 10.52 | 7.90 | 133% |
| Returns for 3 years | 28.70 | 23.62 | 122% |
| Returns for 5 years | 6.85 | -1.69 | -404% |
| Returns for 10 years | 52.66 | 33.44 | 157% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WMKSX | 16.79 | N/A | N/A |
| WesMark Small Company Fund | |||
| VFFSX | 372.53 | N/A | N/A |
| Vanguard 500 Index Institutional Select | |||
| TAISX | 15.51 | N/A | N/A |
| Nuveen Quant Intl Small Cap Eq I | |||
| AGYGX | 12.86 | N/A | N/A |
| American Century Focused Global Gr Y | |||
| JFNCX | 64.59 | -1.74 | -2.62% |
| Janus Henderson Global Life Sciences C | |||